all report title image
  • Published In : May 2026
  • Code : CMI2631
  • Pages : 151
  • Formats :
      Excel/PDF
  • Industry : Pharmaceutical

Immuno-Oncology also known as cancer immunotherapy, is a form of cancer treatment that utilizes immune system of the body to manage, prevent, and destroy cancer. Immuno-oncologists are growing and becoming a part of cancer care group by rapidly increasing the cancer care area. The researchers did study on how to attack cancer by the immune system. Some of them work in labs on creating new treatments and some of them interact between the immune system and cancer cells.

India immuno-oncology drugs market is estimated to be valued at US$ 265 Mn in 2021 and is expected to increase to US$ 550 Mn by 2028, exhibiting a CAGR of 13.1% over the forecast period.

Market Dynamics

The rising incidence of cancer, introduction of novel immuno-oncology therapies with lesser side effects, increasing government engagement to increase cancer diagnosis, and increasing adoption of inorganic growth strategies such as mergers, acquisitions, partnerships, and collaborations by key players operating in the market are the major factors that are expected to drive the growth of the Indian immuno-oncology drugs market over the forecast period.

According to the National Cancer Registry Programme (NCRP), India, one woman dies of cervical cancer every 8 minutes in India. For every 2 women newly diagnosed with breast cancer, one woman dies of it in India. Furthermore, as many people die every day due to tobacco-related cancer diseases in India. Tobacco (smoked and smokeless) use accounted for around 317,928 deaths in men and women, in 2018.

Moreover, The WHO also suggested that people with low and middle income countries should have necessary data for cancer policies because of lack of awareness for treatment availability.         

Key features of the study

  • This report provides an in-depth analysis of the India immuno-oncology drugs market provides market size (US$ Mn) and compound annual growth rate (CAGR%) for the forecast period (2021–2028), considering 2020 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends,  regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the India immuno-oncology drugs market based on the following parameters – company overview, financial performance, product portfolio, market presence, distribution strategies, key developments, strategies, and future plans
  • Key companies covered as a part of this study include Amgen Inc., F. Hoffmann-La Roche AG., Intas Pharmaceuticals Ltd., AstraZeneca plc, Mylan N.V., Dr. Reddy's Laboratories, Bristol - Myers Squibb, Merck & Co., Inc., BIOCAD-Biotechnology company, Reliance Life Sciences, Biocon Limited, and Hetero Drugs Limited
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • The India immuno-oncology drugs market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the India immuno-oncology drugs market

Market Segmentation

  • By Drug Type (Revenue, USD Bn, 2021-2033)
    • Immune Checkpoint Inhibitors
      • Nivolumab
      • Atezolimumab
      • Pembrolizuma
      • Durvalumab
    • Monoclonal Antibodies
      • Rituximab
      • Trastazumab
      • Bevacizumab
      • Nimotuzumab
      • Pertuzumab
      • Ado-Trastuzumab Emtansine
    • Cancer Vaccines
      • Gardasil
      • Cervarix
  • By Cancer Type (Revenue, USD Bn, 2021-2033)
    • Lung Cancer
    • Blood Cancer
    • Breast Cancer
    • Ovarian Cancer
    • Cervical Cancer
    • Colorectal Cancer
    • Stomach Cancer
    • Head & Neck Cancer
    • Others
  • By Distribution Channel (Revenue, USD Bn, 2021-2033)
    • Online Pharmacies
    • Retail Pharmacies
    • Hospital Pharmacies
  • Key Players
    • Amgen Inc.
    • Hoffmann-La Roche AG.
    • Intas Pharmaceuticals Ltd.
    • AstraZeneca plc
    • Mylan N.V.
    • Reddy's Laboratories
    • Bristol - Myers Squibb
    • Merck & Co., Inc.
    • BIOCAD-Biotechnology company
    • Reliance Life Sciences
    • Biocon Limited
    • Hetero Drugs Limited

Table of Contents

  1. Research Objectives and Assumptions
    • Research Objectives
    • Assumptions
    • Abbreviations
  2. Market Purview
    • Report Description
      • Market Definition and Scope
    • Executive Summary
      • Market Snapshot, By Drug Type
      • Market Snapshot, By Cancer Type
      • Market Snapshot, By Distribution Channel
    • Coherent Opportunity Map (COM)
  3. Market Dynamics, Regulations, and Trends Analysis
    • Market Dynamics
    • Drivers
    • Restraints
    • Market Opportunities
    • Impact Analysis
    • Market Trends
    • Key Developments
    • Product Approval
    • Collaboration/Merge/Acquisition
    • Regulatory Landscape
    • PEST Analysis
    • Porter’s Five Forces Analysis
    • Epidemiology
    • Robust Pipeline Analysis
  4. India Immuno-Oncology Drugs Market, By Drug Type, 2021 – 2033, (USD Billion)
    • Introduction
      • Market Share Analysis, 2026 and 2033 (%)
      • Y-o-Y Growth Analysis, 2022– 2033
      • Segment Trends
    • Immune Checkpoint Inhibitors
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Billion)
      • Segment Trends
        • Nivolumab
        • Atezolimumab
        • Pembrolizuma
        • Durvalumab
    • Monoclonal Antibodies
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Billion)
      • Segment Trends
        • Rituximab
        • Trastazumab
        • Bevacizumab
        • Nimotuzumab
        • Pertuzumab
        • Ado-Trastuzumab Emtansine
    • Cancer Vaccines
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Billion)
      • Segment Trends
        • Gardasil
        • Cervarix
  5. India Immuno-Oncology Drugs Market, By Cancer Type, 2021 – 2033, (USD Billion)
    • Introduction
      • Market Share Analysis, 2026 and 2033 (%)
      • Y-o-Y Growth Analysis, 2022 – 2033
      • Segment Trends
    • Lung Cancer
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Billion)
    • Blood Cancer
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Billion)
    • Breast Cancer
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Billion)
    • Ovarian Cancer
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Billion)
    • Cervical Cancer
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Billion)
    • Colorectal Cancer
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Billion)
    • Stomach Cancer
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Billion)
    • Head & Neck Cancer
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Billion)
    • Others
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Billion)
  6. India Immuno-Oncology Drugs Market, By Distribution Channel, 2021 – 2033, (USD Billion)
    • Introduction
      • Market Share Analysis, 2026 and 2033 (%)
      • Y-o-Y Growth Analysis, 2022 – 2033
      • Segment Trends
    • Online Pharmacies
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Billion)
    • Retail Pharmacies
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Billion)
    • Hospital Pharmacies
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Billion)
  7. Competitive Landscape
    • Heat Map Analysis
    • Market Share Analysis
    • Company Profile
      • Amgen Inc.
        • Company Highlights
        • Product Portfolio
        • Financial Performance
        • Recent Highlights
        • Market Strategies
      • F. Hoffmann-La Roche AG.
        • Company Highlights
        • Product Portfolio
        • Financial Performance
        • Recent Highlights
        • Market Strategies
      • Intas Pharmaceuticals Ltd.
        • Company Highlights
        • Product Portfolio
        • Financial Performance
        • Recent Highlights
        • Market Strategies
      • AstraZeneca plc
        • Company Highlights
        • Product Portfolio
        • Financial Performance
        • Recent Highlights
        • Market Strategies
      • Mylan N.V.
        • Company Highlights
        • Product Portfolio
        • Financial Performance
        • Recent Highlights
        • Market Strategies
      • Dr. Reddy's Laboratories
        • Company Highlights
        • Product Portfolio
        • Financial Performance
        • Recent Highlights
        • Market Strategies
      • Bristol - Myers Squibb
        • Company Highlights
        • Product Portfolio
        • Financial Performance
        • Recent Highlights
        • Market Strategies
      • Merck & Co., Inc.
        • Company Highlights
        • Product Portfolio
        • Financial Performance
        • Recent Highlights
        • Market Strategies
      • BIOCAD-Biotechnology company
        • Company Highlights
        • Product Portfolio
        • Financial Performance
        • Recent Highlights
        • Market Strategies
      • Reliance Life Sciences
        • Company Highlights
        • Product Portfolio
        • Financial Performance
        • Recent Highlights
        • Market Strategies
      • Biocon Limited
        • Company Highlights
        • Product Portfolio
        • Financial Performance
        • Recent Highlights
        • Market Strategies
      • Hetero Drugs Limited
        • Company Highlights
        • Product Portfolio
        • Financial Performance
        • Recent Highlights
        • Market Strategies
    • Analyst Views
  8. Section
    • References
    • Research Methodology
    • About Us

View Our Licence Options

  • Need a Custom Report?

    We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports

    Customize Now
Logo

Credibility and Certifications

ESOMAR
DUNS Registered

860519526

Clutch
Credibility and Certification
Credibility and Certification

9001:2015

Credibility and Certification

27001:2022

EXISTING CLIENTELE

Joining thousands of companies around the world committed to making the Excellent Business Solutions.

View All Our Clients
trusted clients logo
© 2026 Coherent Market Insights Pvt Ltd. All Rights Reserved.